Tag:
Promus stent
Latest Headlines
Latest Headlines
Boston Sci touts long-term safety of Promus stent, despite FDA warning
Boston Scientific unveiled the results of a two-year safety study on its Promus Element drug-eluting stents, boasting of "excellent" results for the device.
FDA requires Boston Scientific to caution docs on stent problem
The FDA is evaluating reports about a rare but serious problem--known as longitudinal stent deformation--associated with Boston Scientific's ( $BSX ) Promus Element heart stents and is requiring the
Boston Scientific gets FDA nod for heart stent
Boston Scientific ( $BSX ) has received the FDA's OK for the Promus Element system everolimus-eluting stent, which the company will begin marketing immediately. The transition to the Promus Element
Appeals court finds for Boston Sci in stent case
A federal appeals court has given Boston Scientific a victory in a patent-infringement dispute with Johnson & Johnson in a case involving drug-eluting stents. The U.S. Court of Appeals for the
